Cancer Testis Antigens: A Novel Target in Lung Cancer-Reference-Cited by-同舟云学术

Cancer Testis Antigens: A Novel Target in Lung Cancer

Published:2012-10-19 Issue:5 Volume:31 Page:321-343
ISSN:0883-0185
Container-title:International Reviews of Immunology
language:en
Short-container-title:International Reviews of Immunology

Author:

Chiriva-Internati Maurizio,Pandey Apurva,Saba Radhi,Kim Minji,Saadeh Charles,Lukman Tiajani,Chiaramonte Raffaella,Jenkins Marjorie,Cobos Everardo,Jumper Cynthia,Alalawi Read

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.3109/08830185.2012.723512

Reference88 articles.

1. Global Cancer Statistics, 2002

2. Cancer Statistics, 2009

3. Characterization of two non-testis-specific CABYR variants that bind to GSK3β with a proline-rich extensin-like domain

4. Cancer/testis antigens: an expanding family of targets for cancer immunotherapy

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel automated immunoassay for serum NY-ESO-1 and XAGE1 antibodies in combinatory prediction of response to anti-programmed cell death-1 therapy in non-small-cell lung cancer;Clinica Chimica Acta;2021-08

2. Photodynamic Therapy and Antitumor Immune Response;Cancer Immunology;2020-09-25

3. Cancer Immunotherapy Confers a Global Benefit;Cancer Immunology;2020

4. Serum Antibody Against NY-ESO-1 and XAGE1 Antigens Potentially Predicts Clinical Responses to Anti–Programmed Cell Death-1 Therapy in NSCLC;Journal of Thoracic Oncology;2019-12

5. Detection of autoantibodies against cancer-testis antigens in non-small cell lung cancer;Lung Cancer;2018-11